ALPS Group, Inc. (ALPS)
0.385
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
ALPS Group Total Liabilities (Quarterly) : 12.97M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 12.97M |
| June 30, 2025 | 14.57M |
| March 31, 2025 | 10.88M |
| December 31, 2024 | 11.73M |
| September 30, 2024 | 9.972M |
| June 30, 2024 | 9.482M |
| March 31, 2024 | 8.890M |
| December 31, 2023 | 8.560M |
| September 30, 2023 | 7.190M |
| Date | Value |
|---|---|
| June 30, 2023 | 6.786M |
| March 31, 2023 | 76.33M |
| December 31, 2022 | 4.970M |
| September 30, 2022 | 4.725M |
| June 30, 2022 | 4.320M |
| March 31, 2022 | 4.324M |
| December 31, 2021 | 4.370M |
| September 30, 2021 | 0.0948M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bio Green Med Solution, Inc. | 0.694M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Agenus, Inc. | 378.54M |
| Alkermes Plc | 2.585B |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.740M |
| Shareholders Equity (Quarterly) | -11.23M |